Trump administration plans to expand health care coverage for weight loss drugs

Latest News

08-02

Weight-loss drugs may be coming to Medicare, Medicaid under experimental program

08-01

美医保拟覆盖礼来(LLY.US)诺和诺德(NVO.US)GLP-1减肥药，2026年起试点落地

08-01

诺和诺德、礼来迎利好，消息称美国拟扩大对减肥药的医保覆盖范围

User Discussion

airevo

08-03

$Novo-Nordisk A/S(NVO)$ nive

Trump administration to pilot coverage of weight‑loss drugs under Medicare and Medicaid, Washington Post reports

{"i18n":{"language":"en_US"},"financialEventData":{"themeId":"41e1821401322ad521e325e6c51e4e44","name":"Trump administration plans to expand health care coverage for weight loss drugs","description":"The Trump administration plans to pilot coverage of weight-loss drugs under Medicare and Medicaid.","image":"https://community-static.tradeup.com/news/1201dcc0482be040348fb8d4f228bb68","type":2,"style":4,"follow":false,"createTime":1754049344254,"userCounts":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/special/finance&rndata={\"themeId\":41e1821401322ad521e325e6c51e4e44}&rnconfig={\"headerBarHidden\": true}","subscribe":false,"allowFollow":false,"hasReward":false,"rewardScore":0,"rewardValidDate":0,"rewardEnd":false,"symbols":["NVO"],"tweetCounts":1,"categoryId":"2929bb7468f5415f853fd96fb35d7c3b","options":[],"votedOptionId":"","totalUserCount":0,"followStatus":false,"themeName":"Trump administration plans to expand health care coverage for weight loss drugs","tweetAmount":1,"imageIsDefault":false,"aiDerivativeIssues":[]},"news":[{"id":323267,"article_id":"2556684591","title":"Weight-loss drugs may be coming to Medicare, Medicaid under experimental program","subtitle":"","subtitle_show":0,"pub_time":1754079180000,"source_id":"dowjones_highlight","language":"en","url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":0,"symbols_score_info":{"LLY":1},"rights":null},{"id":323052,"article_id":"2556816224","title":"美医保拟覆盖礼来(LLY.US)诺和诺德(NVO.US)GLP-1减肥药，2026年起试点落地","subtitle":"","subtitle_show":0,"pub_time":1754053581000,"source_id":"live_zhitongcaijing","language":"zh","url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":0,"symbols_score_info":{"159891":1,"GLP":1,"LLY":1,"NVO":1},"rights":null},{"id":322980,"article_id":"1190033103","title":"诺和诺德、礼来迎利好，消息称美国拟扩大对减肥药的医保覆盖范围","subtitle":"","subtitle_show":0,"pub_time":1754048559614,"source_id":"","language":"zh","url":"","is_publish_highlight":1,"symbols_score_info":{"LLY":1.1,"NVO":1.1},"rights":null},{"id":322971,"article_id":"2556388813","title":"诺和诺德美股盘前涨超2%，此前一度跌近3%，消息称美国拟扩大减肥药医保覆盖范围。","subtitle":"","subtitle_show":0,"pub_time":1754048507000,"source_id":"live_gelonghui","language":"zh","url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":0,"symbols_score_info":{"NVO":1},"rights":null},{"id":322976,"article_id":"1119361125","title":"礼来股价因Medicare、Medicaid覆盖减肥药物报告而上涨","subtitle":"","subtitle_show":0,"pub_time":1754044960460,"source_id":"美股洞察","language":"zh","url":"","is_publish_highlight":0,"symbols_score_info":{"LLY":1},"rights":null},{"id":322974,"article_id":"1165356036","title":"礼来股价盘前上涨1.3%，此前有报道称Medicare和Medicaid计划试验覆盖减肥药物","subtitle":"","subtitle_show":0,"pub_time":1754043501215,"source_id":"美股速递","language":"zh","url":"","is_publish_highlight":0,"symbols_score_info":{"LLY":1},"rights":null},{"id":322978,"article_id":"1140513862","title":"特朗普政府计划在Medicare和Medicaid下试点覆盖减肥药物","subtitle":"","subtitle_show":0,"pub_time":1754043155323,"source_id":"美股洞察","language":"zh","url":"","is_publish_highlight":0,"symbols_score_info":{"LLY":1},"rights":null},{"id":322979,"article_id":"2556891072","title":"据《华盛顿邮报》报道，特朗普政府将在医疗保险和医疗补助计划下试点承保减肥药","subtitle":"","subtitle_show":0,"pub_time":1754043049000,"source_id":"reuters_news_zh","language":"zh","url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nL4S3TT0TN:1","is_publish_highlight":0,"symbols_score_info":{"LLY":0.9},"rights":null},{"id":322975,"article_id":"2556910708","title":"Trump administration to pilot coverage of weight‑loss drugs under Medicare and Medicaid, Washington Post reports","subtitle":"","subtitle_show":0,"pub_time":1754043043000,"source_id":"reuters_news_en","language":"en","url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nFWN3TT146:1","is_publish_highlight":0,"symbols_score_info":{"LLY":0.9},"rights":null},{"id":322973,"article_id":"1157285291","title":"Medicare、Medicaid计划试验覆盖减肥药物","subtitle":"","subtitle_show":0,"pub_time":1754042826467,"source_id":"美股速递","language":"zh","url":"","is_publish_highlight":0,"symbols_score_info":{"LLY":1},"rights":null},{"id":322977,"article_id":"2556891278","title":"Medicare, Medicaid Plans to Experiment With Covering Weight Loss Drugs - Washington Post","subtitle":"","subtitle_show":0,"pub_time":1754042741921,"source_id":"reuters_en_live","language":"en","url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nFWN3TT146:1","is_publish_highlight":0,"symbols_score_info":{"LLY":0.9},"rights":null}],"views":[],"tweetList":[{"id":463494696137016,"gmtCreate":1754187764803,"gmtModify":1754187768009,"author":{"id":"4162461213962292","authorId":"4162461213962292","name":"airevo","avatar":"https://community-static.tradeup.com/news/d063fe33be16b538bdd93f39cd95c474","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4162461213962292","idStr":"4162461213962292"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a> nive","listText":"<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a> nive","text":"$Novo-Nordisk A/S(NVO)$ nive","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/463494696137016","repostId":"2556910708","repostType":2,"repost":{"id":"2556910708","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"pubTimestamp":1754043043,"share":"https://ttm.financial/m/news/2556910708?lang=en_US&edition=fundamental","pubTime":"2025-08-01 18:10","market":"nz","language":"en","title":"Trump administration to pilot coverage of weight‑loss drugs under Medicare and Medicaid, Washington Post reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2556910708","media":"Reuters","summary":"Trump administration to pilot coverage of weightloss drugs under Medicare and Medicaid, Washington Post reportsAug 1 (Reuters) - The Trump administration is planning an experiment to cover weight-loss","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Trump administration to pilot coverage of weight‑loss drugs under Medicare and Medicaid, Washington Post reports</title></head><body><p><span>Aug 1 (Reuters)</span><span> - </span>The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington Post reported on Friday.</p><p> (Reporting by Surbhi Misra in Bengaluru; Editing by Sharon Singleton)</p><p> ((Surbhi.Misra@thomsonreuters.com |  X: https://twitter.com/SurbhiMisra_  |;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Trump administration to pilot coverage of weight‑loss drugs under Medicare and Medicaid, Washington Post reports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTrump administration to pilot coverage of weight‑loss drugs under Medicare and Medicaid, Washington Post reports\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-08-01 18:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Trump administration to pilot coverage of weight‑loss drugs under Medicare and Medicaid, Washington Post reports</title></head><body><p><span>Aug 1 (Reuters)</span><span> - </span>The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington Post reported on Friday.</p><p> (Reporting by Surbhi Misra in Bengaluru; Editing by Sharon Singleton)</p><p> ((Surbhi.Misra@thomsonreuters.com |  X: https://twitter.com/SurbhiMisra_  |;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4588":"碎股","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","LU1232071149.USD":"AZ FUND 1 GLOBAL GROWTH SELECTOR \"AAZ\" (USDHDG) ACC","LU2237443978.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc SGD-H","IE00BJLML261.HKD":"HSBC GLOBAL EQUITY INDEX \"HCH\" (HKD) ACC","LLY":"礼来","LU0323591593.USD":"SCHRODER ISF QEP GLOBAL QUALITY \"A\" (USD) ACC","SG9999014914.USD":"UNITED GLOBAL QUALITY GROWTH (USDHDG) INC","LU1267930730.SGD":"富兰克林美国机遇基金AS Acc SGD (CPF)","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","LU0109391861.USD":"富兰克林美国机遇基金A Acc","LU2552382215.SGD":"WELLINGTON US BRAND POWER \"A\" (SGDHDG) ACC","LU0708995401.HKD":"FRANKLIN U.S. OPPORTUNITIES \"A\" (HKD) ACC","LU0094547139.USD":"abrdn SICAV I - GLOBAL SUSTAINABLE EQUITY FUND \"A\" (USD) ACC","LU2491050154.USD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (USD) ACC","LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","LU2264538146.SGD":"Fullerton Lux Funds - Global Absolute Alpha A Acc SGD","BK4599":"减肥药","LU2361044949.HKD":"WELLINGTON US QUALITY GROWTH \"A\" (HKD) ACC","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","LU2461242641.AUD":"WELLINGTON US QUALITY GROWTH \"A\" (AUDHDG) ACC","SG9999015986.USD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (USD) ACC","SG9999014906.USD":"大华全球优质成长基金Acc USD","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","IE00BK4W5M84.HKD":"HSBC GLOBAL FUNDS ICAV US EQUITY INDEX \"HC\" (HKD) ACC","LU0097036916.USD":"贝莱德美国增长A2 USD","SG9999015978.USD":"利安颠覆性创新基金A","LU2211815571.USD":"ALLIANZ POSITIVE CHANGE \"AT\" (USD) ACC","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU0882574055.USD":"富达全球健康医疗A ACC","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","SGXZ51526630.SGD":"大华环球创新基金A Acc SGD","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","BK4533":"AQR资本管理(全球第二大对冲基金)","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","LU1064131342.USD":"Fullerton Lux Funds - Global Absolute Alpha A Acc USD","LU1069344957.HKD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (HKD) INC","LU0058720904.USD":"联博国际健康护理基金A","LU2108987350.USD":"UBS (LUX) EQUITY SICAV GLOBAL OPPORTUNITY SUSTAINABLE (USD) \"P\" (USD) ACC","LU2063271972.USD":"富兰克林创新领域基金","SG9999015945.SGD":"LionGlobal Disruptive Innovation Fund A SGD","LU0385154629.USD":"贝莱德营养科学基金A2","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU2237443549.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA SGD-H","LU2237443895.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) ACC"},"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nFWN3TT146:1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2556910708","content_text":"Trump administration to pilot coverage of weight‑loss drugs under Medicare and Medicaid, Washington Post reportsAug 1 (Reuters) - The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington Post reported on Friday. (Reporting by Surbhi Misra in Bengaluru; Editing by Sharon Singleton) ((Surbhi.Misra@thomsonreuters.com |  X: https://twitter.com/SurbhiMisra_  |;))","news_type":1,"symbols_score_info":{"LLY":0.9}},"isVote":1,"tweetType":1,"viewCount":441,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}]}